Search

Author/Creator D'Souza, A.

5. Passive transfer of antibodies to the linear epitope 60 kD Ro 273–289 induces features of Sjögren's syndrome in naive mice. (April 2015)

Authors:
Maier‐Moore, J. S.; Kurien, B. T.; D'Souza, A.; Bockus, L.; Asfa, S.; Dorri, Y.; Hubbell, S.; Yeliosof, O.; Obeso, D.; Schoeb, T. R.; Jonsson, R.; Scofield, R. H.
Journal:
Clinical and experimental immunology
Issue:
Volume 180:Number 1(2015:Apr.)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. S183: NOVEL COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS FOR TALQUETAMAB (A GPRC5D X CD3 BISPECIFIC ANTIBODY) IN COMBINATION WITH DARATUMUMAB. (23rd June 2022)

Authors:
van de Donk, N. W.; Bahlis, N.; Mateos, M.-V.; Weisel, K.; Dholaria, B.; Garfall, A. L.; Goldschmidt, H.; Martin, T. G.; Morillo, D.; Reece, D. E.; Hurd, D.; Rodríguez-Otero, P.; Bhutani, M.; D'Souza, A.; Oriol, A.; Askari, E.; San-Miguel, J. F.; Kortüm, K. M.; Vishwamitra, D.; Xin Wang Lin, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
84
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS. (23rd June 2022)

Authors:
Rodriguez Otero, P.; D'Souza, A.; Reece, D.; van de Donk, N. W.; Chari, A.; Krishnan, A.; Martin, T.; Mateos, M. V.; Morillo, D.; Hurd, D.; Rosinol, L.; Balari, A. S.; Wäsch, R.; Vishwamitra, D.; Wang Lin, S. X.; Prior, T.; Vandenberk, L.; Smit, M.-A. D.; Oriol, A.; Dholaria, B.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
89
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗